Since 2019, the SARS-CoV-2 that produces COVID-19 has tragically highlighted the fragility of humanity to new coronaviruses by killing 6.3 million people globally. In order to combat SARS-CoV-2 and all of its potentially dangerous variations, namely Beta, Gamma, Delta, Epsilon, and Omicron, researchers have discovered a neutralising monoclonal antibody. The deadly prior coronaviruses, SARS-CoV, the […]

The post Universal Coronavirus Monoclonal Therapy For COVID-19 Strain first appeared on World Pharma Today.